🇺🇸 FDA
Pipeline program

dutasteride 0.5mg once daily for 4 years

ARI40005

Phase 3 small_molecule completed

Quick answer

dutasteride 0.5mg once daily for 4 years for Prostatic Hyperplasia is a Phase 3 program (small_molecule) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).

Program details

Company
GlaxoSmithKline
Indication
Prostatic Hyperplasia
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials